Abstract
The aim of this study was to assess the effect of rosiglitazone on endothelial function and inflammatory markers in patients with the metabolic syndrome. This was a randomized, double-blind, controlled clinical trial. One hundred subjects (54 men and 46 women) with the metabolic syndrome, as defined by the Adult Treatment Panel III, were followed for 12 months after random assignment to rosiglitazone (4 mg/day) or placebo. Primary end points were flow-mediated dilation and high-sensitivity C-reactive protein (hs-CRP) levels; secondary end points were lipid and glucose parameters, homeostasis model assessment (HOMA) of insulin sensitivity, endothelial function score, and circulating levels of interleukin (IL)-6, IL-18, and adiponectin. Compared with 60 control subjects matched for age and sex, patients with the metabolic syndrome had decreased endothelial function, raised concentrations of inflammatory markers, and reduced insulin sensitivity. After 12 months, subjects with the metabolic syndrome receiving rosiglitazone showed improved flow-mediated vasodilation (4.2%, P < 0.001) and reduced hs-CRP levels (-0.7 mg/dl, P = 0.04), compared with the placebo group. Moreover, HOMA (-0.8, P = 0.01) and serum concentrations of IL-6 (-0...Continue Reading
Citations
Feb 12, 2013·Reviews in Endocrine & Metabolic Disorders·Kieren J Mather
Mar 1, 2008·PPAR Research·Cadence E MingeRobert J Norman
Aug 8, 2012·Circulation·Andreas J FlammerAmir Lerman
Jan 8, 2008·World Journal of Gastroenterology : WJG·Eric R KallwitzScott J Cotler
Dec 17, 2008·World Journal of Gastroenterology : WJG·Hai-Ning WangTian-Pei Hong
Dec 23, 2011·PPAR Research·Zhigang ZhaoZhiming Zhu
Apr 24, 2013·Annals of the American Thoracic Society·Imran H IftikharUlysses J Magalang
Sep 3, 2010·Menopause : the Journal of the North American Menopause Society·Domenico GiordanoRosario D'Anna
Jul 6, 2007·Expert Review of Neurotherapeutics·Xiaoduo FanDavid C Henderson
Apr 22, 2008·Expert Opinion on Pharmacotherapy·C V RizosM S Elisaf
Jun 15, 2007·Expert Opinion on Pharmacotherapy·Dawn Smiley, Guillermo Umpierrez
Mar 9, 2010·Journal of the Formosan Medical Association = Taiwan Yi Zhi·I-Chih ChenYi-Heng Li
Sep 24, 2011·Experimental Diabetes Research·Sridevi Devaraj, Ishwarlal Jialal
Sep 21, 2007·Molecular Nutrition & Food Research·Katherine EspositoDario Giugliano
Nov 9, 2007·Diabetes/metabolism Research and Reviews·Antonio Ceriello
Apr 1, 2008·European Journal of Pharmacology·Luis M Blanco-ColioJesús Egido
Jun 26, 2007·Atherosclerosis·T ForstA Pfützner
Jul 20, 2007·Progress in Lipid Research·Nikolaus Marx, Daniel Walcher
Sep 22, 2009·European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences·Ashish Kumar Sharma, B P Srinivasan
Feb 18, 2015·BMJ Open·Katherine EspositoDario Giugliano
May 29, 2016·Therapeutic Advances in Cardiovascular Disease·Dragana LovreFranck Mauvais-Jarvis
May 1, 2007·American Journal of Lifestyle Medicine·Michael G FlynnMelissa M Markofski
Nov 5, 2011·Journal of Cardiovascular Pharmacology and Therapeutics·Kumar PerampaladasJohn D Parker